Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 289
Selected: 0
NCT IDTitle
NCT00392782Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT05705700Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP)
NCT03019666Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
NCT01639456CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission
NCT01593670Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
NCT00305682Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant
NCT04055844Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
NCT04228952Metabolism of NNK in Japanese Americans
NCT04855253Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL
NCT00686556Total Marrow Irradiation for Refractory Acute Leukemia
NCT02309944Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
NCT00668564Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
NCT05700630Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT00638820Reduced Intensity AlloTransplant For Osteopetrosis
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT06872333Allo HSCT for High Risk Hemoglobinopathies
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT07008638Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT04225572Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT)
NCT01962636Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
NCT02670837Study of Cellutome System for Treatment of Individual Lesions in EB Pts
NCT04105270RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
NCT00352976TBI Dose De-escalation for Fanconi Anemia
NCT00432094Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
NCT03421678Ethnic/Racial Differences in Metabolism and DNA Adduct Formation
NCT00357565Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia
NCT00167167Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
NCT04514471Feasibility Study - Filter Ventilation
NCT03417154Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT00625729Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
NCT02162420Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
NCT01385423Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)
NCT03316456Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
NCT05025774Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
NCT03678493A Study of FMT in Patients With AML Allo HSCT in Recipients
NCT02765997StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
NCT01593618Empowering Cancer Survivors Through Information Technology
NCT06544811American Indian Smokefree Native RCT
NCT05114837Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
NCT03609203Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
NCT06342986Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT00290654Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
NCT04284254MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT
NCT01581970Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
NCT00176826T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders